Lazard Asset Management LLC acquired a new stake in shares of Auna S.A. (NYSE:AUNA – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 101,102 shares of the company’s stock, valued at approximately $557,000. Lazard Asset Management LLC owned about 0.14% of Auna at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of AUNA. Renaissance Technologies LLC lifted its stake in Auna by 487.7% during the 1st quarter. Renaissance Technologies LLC now owns 668,457 shares of the company’s stock valued at $3,683,000 after acquiring an additional 554,707 shares during the period. Marshall Wace LLP raised its holdings in shares of Auna by 391.0% during the fourth quarter. Marshall Wace LLP now owns 162,992 shares of the company’s stock valued at $802,000 after purchasing an additional 129,799 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Auna by 43.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 71,645 shares of the company’s stock valued at $352,000 after purchasing an additional 21,579 shares during the last quarter. Hsbc Holdings PLC bought a new position in Auna during the first quarter valued at approximately $324,000. Finally, Arrowstreet Capital Limited Partnership purchased a new stake in Auna in the first quarter worth approximately $316,000.
Insider Buying and Selling at Auna
In related news, President Leon Jesus Zamora acquired 30,000 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The shares were purchased at an average price of $4.39 per share, with a total value of $131,700.00. Following the completion of the purchase, the president directly owned 45,914 shares of the company’s stock, valued at $201,562.46. This represents a 188.51% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John Wilton sold 17,574 shares of Auna stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $4.17, for a total value of $73,283.58. Following the transaction, the director directly owned 49,974 shares in the company, valued at approximately $208,391.58. The trade was a 26.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have purchased 83,454 shares of company stock worth $357,063 over the last quarter.
Wall Street Analyst Weigh In
Get Our Latest Stock Report on Auna
Auna Stock Up 0.2%
AUNA opened at $5.22 on Friday. The company has a current ratio of 1.09, a quick ratio of 1.00 and a debt-to-equity ratio of 1.76. Auna S.A. has a 1-year low of $4.09 and a 1-year high of $6.85. The company has a market capitalization of $386.48 million, a PE ratio of 20.09 and a beta of 0.61. The firm’s 50 day simple moving average is $5.03 and its two-hundred day simple moving average is $5.11.
Auna (NYSE:AUNA – Get Free Report) last issued its quarterly earnings data on Friday, May 15th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.14). The business had revenue of $336.84 million for the quarter, compared to the consensus estimate of $320.54 million. Auna had a net margin of 1.53% and a return on equity of 16.25%. As a group, equities analysts forecast that Auna S.A. will post 0.79 EPS for the current year.
Auna Profile
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
Read More
- Five stocks we like better than Auna
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
